Nov 10, 2024, 03:26
NCCN guidelines recommend genetic testing for all metastatic Prostate Cancer patients – Prostate Cancer Foundation
Prostate Cancer Foundation shared a post on X:
“NCCN guidelines recommend genetic testing for all metastatic Prostate cancer patients and those with high-risk features or Ashkenazi Jewish heritage.
Over 20% of patients with mCRPC have DNA repair gene alterations. How do you discuss testing with your patients?”
Proceed to the video attached to the post.
For more posts like this, visit oncodaily.com.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33
Dec 21, 2024, 13:20